ArticleJournal of medicinal chemistry2023

Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications.

Raghuvir Haridas Gaonkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.